Iconiq Capital’s Niagen Bioscience NAGE Stock Holding History

Iconiq Capital’s Portfolio NAGE Stock Details NAGE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-585,347	Closed	-$4.04M	–	459
2025 Q1	$4.04M	Sell	585,347 -711,007	-55%	-$4.47M	0.07%	46
2024 Q4	$6.88M	Hold	1,296,354	–	–	0.11%	39
2024 Q3	$4.73M	Hold	1,296,354	–	–	0.1%	37
2024 Q2	$3.54M	Hold	1,296,354	–	–	0.08%	38
2024 Q1	$4.51M	Hold	1,296,354	–	–	0.08%	31
2023 Q4	$1.85M	Hold	1,296,354	–	–	0.03%	36
2023 Q3	$1.89M	Hold	1,296,354	–	–	0.04%	34
2023 Q2	$2.04M	Hold	1,296,354	–	–	0.03%	34
2023 Q1	$1.98M	Hold	1,296,354	–	–	0.03%	38
2022 Q4	$2.18M	Hold	1,296,354	–	–	0.03%	35
2022 Q3	$1.59M	Hold	1,296,354	–	–	0.02%	39
2022 Q2	$2.17M	Hold	1,296,354	–	–	0.03%	41
2022 Q1	$3.18M	Hold	1,296,354	–	–	0.02%	36
2021 Q4	$4.85M	Hold	1,296,354	–	–	0.03%	37
2021 Q3	$8.13M	Hold	1,296,354	–	–	0.05%	30
2021 Q2	$12.8M	Hold	1,296,354	–	–	0.08%	27
2021 Q1	$12.1M	Sell	1,296,354 -410,963	-24%	-$3.26M	0.14%	21
2020 Q4	$8.2M	Hold	1,707,317	–	–	0.2%	28
2020 Q3	$6.85M	Hold	1,707,317	–	–	0.4%	29
2020 Q2	$7.84M	Hold	1,707,317	–	–	0.55%	19
2020 Q1	$5.57M	Hold	1,707,317	–	–	0.5%	21
2019 Q4	$7.36M	Hold	1,707,317	–	–	0.55%	22
2019 Q3	$6.73M	Hold	1,707,317	–	–	0.27%	22
2019 Q2	$7.94M	Hold	1,707,317	–	–	0.49%	16
2019 Q1	$7.15M	Hold	1,707,317	–	–	0.76%	14
2018 Q4	$5.86M	Hold	1,707,317	–	–	0.83%	14
2018 Q3	$7.32M	Hold	1,707,317	–	–	0.77%	14
2018 Q2	$6.33M	Hold	1,707,317	–	–	0.78%	16
2018 Q1	$7.17M	Hold	1,707,317	–	–	0.81%	14
2017 Q4	$10M	Buy	+1,707,317	New	+$9.22M	1.04%	13

Other funds holding NAGE

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

TCM

Tieton Capital Management Yakima, Washington $299M AUM 54.55% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return

Connor, Clark & Lunn Investment Management (CC&L) Vancouver, British Columbia, Canada $43.4B AUM 51.29% 1-Year Est. Return

Qube Research & Technologies (QRT) London, United Kingdom $89.9B AUM 20.22% 1-Year Est. Return

Iconiq Capital's NAGE Position: Q2 2025 in Review

Iconiq Capital sold out of Niagen Bioscience (NAGE) in Q2 2025, closing a stake of 585,347 shares — an estimated $4.04M sold.

Iconiq Capital first reported a position in NAGE in Q4 2017 and held it in 30 quarters. The position peaked at $12.8M in Q2 2021. 155 funds tracked by Wall St. Rank hold NAGE as of Q2 2025.

Iconiq Capital reported no remaining Niagen Bioscience position as of Q2 2025 after selling out during the quarter.
Iconiq Capital sold 585,347 Niagen Bioscience shares in Q2 2025, an estimated $4.04M.
Iconiq Capital first reported a position in Niagen Bioscience in Q4 2017 and held it in 30 quarters.
Iconiq Capital's Niagen Bioscience position peaked at $12.8M in Q2 2021.
155 funds tracked by Wall St. Rank held Niagen Bioscience as of Q2 2025.

Based on Iconiq Capital's 13F filing for Q2 2025, filed 14 Aug 2025.